Anzeige
+++>>> Milliardenschwere Goldaktie: Steigende Produktionsmengen, operative Hebelwirkung und der Goldpreis könnten zusammen neue Impulse setzen <<<+++
EQS-News

MediCapture Launches aiScope™ Pilot for Veterinary Sciences at VMX 2026 15.01.2026, 10:05 Uhr von EQS News Jetzt kommentieren: 0

EQS-News: MediCapture Inc. / Key word(s): Miscellaneous/Product Launch
MediCapture Launches aiScope™ Pilot for Veterinary Sciences at VMX 2026

15.01.2026 / 10:05 CET/CEST
The issuer is solely responsible for the content of this announcement.


Medical AI Made Easy—From Lab to Real-World Training & Practical Use

CHEROKEE, Texas, Jan. 15, 2026 /PRNewswire/ -- MediCapture Inc., a global leader in medical imaging systems, today announced the launch of aiScope™, software that runs Vision AI models in real-time, locally on MediCapture's MTRs and selected MVR imaging systems. First aiScope™ pilot deployment will be in veterinary science.

AiScope Logo

The technology will be demonstrated live at VMX 2026 in Orlando, Florida, working on MediCapture's VUEES™ University Edition and on portable VUEES™ Mobility platforms. (abbreviated as Veterinary Ultrasound and Endoscopy Education Systems).

Medical AI Made Easy
iScope™ enables real-time object detection, image classification, and AI-assisted video analysis directly on medically certified MediCapture MTR and MVR devices — eliminating the need for external PCs, GPUs, or complex proprietary systems in the operating room or in the field.

"By embedding AI Vision at the point of care, aiScope™ solves the long-standing "last-mile problem" that has prevented many research AI models from being used in real-world clinical and teaching environments", says Bernd Jotzat, Senior Product Manager at MediCapture.

Powerful data collection engine for your Vision AI datasets  
MediCapture MTRs and MVR with aiScope™ turn your surgical camera into a powerful vision data capture device, enabling classification or detection in real-time.

Using custom models, aiScope™ analyses captured images and automatically generates bounding boxes and labels. Future updates will add auto-annotation and pre-annotated exports, cutting manual review and labelling time.

Vendor Neutral and Open Source
aiScope™ is vendor-neutral and operates with an MTR or MVR to run Vision AI applications across endoscopic, microscopic, and surgical camera systems. It supports open source models and training, conversion and deployment of publicly available models, and integration of community-developed models.

First Deployment in Veterinary Education 
The aiScope™ pilot launches on January 15 during VetExpo Europe in Leipzig, Germany, and this Saturday, January 17 at the VMX Expo in Orlando, USA. It will run through the spring, then extend to data collection programs for veterinary universities and research centers for the remainder of 2026.

Medical AI in the Field with VUEES Mobility
MediCapture's MTR with aiScope™ can fit easily into a case the size of a carry-on. Using under 20 watts of power, an MTR can run aiScope for 8+ hours on a quality power bank. MediCapture will demonstrate aiScope on VUEES Mobility™ at VMX 2026 in Orlando, USA, on January 17.

MediCapture President and CEO Michael Bishop explained the company's decision to begin in veterinary science: 
"Veterinary medicine spans more than 65,000 vertebrate species. That's where science begins. That's how discovery accelerates. aiScope™ is portable, allowing us to bring AI-driven imaging to every corner of the earth."

Availability 
aiScope™ planned availability for university pilot participants is in March, 2026 with broader commercial availability on select MediCapture systems early this summer.

About MediCapture  
MediCapture Inc. designs and manufactures innovative imaging, recording, and archiving solutions for medical use in surgery, endoscopy, ultrasound, and clinical education. With a strong focus on vendor-neutral devices, OR integration tools, smart workflow engines, and Vision AI technology, MediCapture empowers human healthcare professionals and veterinary professionals worldwide to capture more, understand more, and teach more. For more information, visit medicapture.com or contact sales@medicapture.com

For Media Inquiries:
Global Marketing Communications Department
marketing@medicapture.com 
MediCapture Inc. – All Rights Reserved 2026

Logo - https://mma.prnewswire.com/media/2861683/AiScope_logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/medicapture-launches-aiscope-pilot-for-veterinary-sciences-at-vmx-2026-302661534.html

rt.gif?NewsItemId=EN63386&Transmission_Id=202601150400PR_NEWS_EURO_ND__EN63386&DateId=20260115


15.01.2026 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News


2260626  15.01.2026 CET/CEST

Kommentare (0) ... diskutiere mit.
Werbung

Handeln Sie Aktien bei SMARTBROKER+ für 0 Euro!* Profitieren Sie von kostenloser Depotführung, Zugriff auf 29 deutsche und internationale Börsenplätze und unschlagbar günstigen Konditionen – alles in einer innovativen, brandneuen App. Jetzt zu SMARTBROKER+ wechseln und durchstarten!

*Ab 500 EUR Ordervolumen über gettex. Zzgl. marktüblicher Spreads und Zuwendungen.

k.A. k.A. k.A. k.A.
k.A. k.A. k.A. k.A.
k.A. k.A. k.A. k.A.
Schreib den ersten Kommentar!

Dis­clai­mer: Die hier an­ge­bo­te­nen Bei­trä­ge die­nen aus­schließ­lich der In­for­ma­t­ion und stel­len kei­ne Kauf- bzw. Ver­kaufs­em­pfeh­lung­en dar. Sie sind we­der ex­pli­zit noch im­pli­zit als Zu­sich­er­ung ei­ner be­stim­mt­en Kurs­ent­wick­lung der ge­nan­nt­en Fi­nanz­in­stru­men­te oder als Handl­ungs­auf­for­der­ung zu ver­steh­en. Der Er­werb von Wert­pa­pier­en birgt Ri­si­ken, die zum To­tal­ver­lust des ein­ge­setz­ten Ka­pi­tals füh­ren kön­nen. Die In­for­ma­tion­en er­setz­en kei­ne, auf die in­di­vi­du­el­len Be­dür­fnis­se aus­ge­rich­te­te, fach­kun­di­ge An­la­ge­be­ra­tung. Ei­ne Haf­tung oder Ga­ran­tie für die Ak­tu­ali­tät, Rich­tig­keit, An­ge­mes­sen­heit und Vol­lständ­ig­keit der zur Ver­fü­gung ge­stel­lt­en In­for­ma­tion­en so­wie für Ver­mö­gens­schä­den wird we­der aus­drück­lich noch stil­lschwei­gend über­nom­men. Die Mar­kets In­side Me­dia GmbH hat auf die ver­öf­fent­lich­ten In­hal­te kei­ner­lei Ein­fluss und vor Ver­öf­fent­lich­ung der Bei­trä­ge kei­ne Ken­nt­nis über In­halt und Ge­gen­stand die­ser. Die Ver­öf­fent­lich­ung der na­ment­lich ge­kenn­zeich­net­en Bei­trä­ge er­folgt ei­gen­ver­ant­wort­lich durch Au­tor­en wie z.B. Gast­kom­men­ta­tor­en, Nach­richt­en­ag­en­tur­en, Un­ter­neh­men. In­fol­ge­des­sen kön­nen die In­hal­te der Bei­trä­ge auch nicht von An­la­ge­in­te­res­sen der Mar­kets In­side Me­dia GmbH und/oder sei­nen Mit­ar­bei­tern oder Or­ga­nen be­stim­mt sein. Die Gast­kom­men­ta­tor­en, Nach­rich­ten­ag­en­tur­en, Un­ter­neh­men ge­hör­en nicht der Re­dak­tion der Mar­kets In­side Me­dia GmbH an. Ihre Mei­nung­en spie­geln nicht not­wen­di­ger­wei­se die Mei­nung­en und Auf­fas­sung­en der Mar­kets In­side Me­dia GmbH und de­ren Mit­ar­bei­ter wie­der. Aus­führ­lich­er Dis­clai­mer